← Evidence map

ArticleCell death discovery2021

Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.

Surein Arulananda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34131107